The Cell Sciences Imaging Facility (CSIF) offers state-of-the-art fluorescence and electron microscopy services to Stanford Cancer Institute researchers. The facility provides investigators with advanced imaging systems to image and analyze the molecular and structural organization of cells and tissue at a microscopic level, crucial for researchers studying the biological mechanisms involved in cancer. The CSIF operates at two sites on the Stanford campus, one at the Beckman Center and the other at the newly built Shriram Center for bioengineering across the street from the medical campus. Both locations are available to all SCI researchers. The CSIF is directed by Jon Mulholland, an experienced microscopist and cell biologist, who oversees its day-to-day management. CSIF occupies a combined total of 3,000 square feet in the Shriram and Beckman centers, and employs five full-time research scientists to assist SCI investigators with microscopy needs. The two imaging facilities have ten advanced light and electron microscope systems that provide confocal, deconvolution, 2-photon and super resolution, as well as electron microscopy technologies. For electron microscopy, the CSIF maintains a full-service laboratory that offers sample preparation and training for both transmission and scanning electron microscopy technologies. Over the last five years, the CSIF has been awarded approximately $2.4 million in instrumentation grants from the NIH's Shared Instrument Grant program. In addition, it has received over $2.2 million in internal instrumentation funding, bringing the total award amount to $4.6 million. The facility operates on a cost-recovery basis, with ongoing expenses recovered primarily through user fees; the resource?s annual operating costs are approximately $1,050,000. Since 2009, over 95 SCI members from all research programs have used the CSIF, with the majority of usage coming from the Cancer Stem Cells, Cancer Biology, TOPS and Immunology & Immunotherapy Programs. Future goals of the CSIF include developing and providing correlative electron to light imaging as well as large volume 3D and array tomography imaging. Further, CSIF plans to apply for the 2015 NIH SIG program for two types of advanced instrumentation: one for an advanced SEM system for serial block face SEM that will enable large volume, 3-dimensional reconstruction of tissue at high enough resolution and second for a bio-AFM that combines advanced atomic force measurements with epifluorescence light imaging modalities that will enable characterization of a cell's mechanobiology and protein/molecular composition.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RTRB-0)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
Domestic Higher Education
United States
Zip Code
Lee, Bee L; Fan, Shenghua K; Lu, Ying (2017) A curve-free Bayesian decision-theoretic design for two-agent Phase I trials. J Biopharm Stat 27:34-43
Mohanty, Suchismita; Chen, Zixin; Li, Kai et al. (2017) A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival. Mol Cancer Ther 16:1909-1921
Alcántara-Hernández, Marcela; Leylek, Rebecca; Wagar, Lisa E et al. (2017) High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. Immunity 47:1037-1050.e6
Chao, Mark P; Gentles, Andrew J; Chatterjee, Susmita et al. (2017) Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. Cell Stem Cell 20:329-344.e7
Rogers, Zoë N; McFarland, Christopher D; Winters, Ian P et al. (2017) A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nat Methods 14:737-742
Sun, Ruping; Hu, Zheng; Sottoriva, Andrea et al. (2017) Between-region genetic divergence reflects the mode and tempo of tumor evolution. Nat Genet 49:1015-1024
Jin, Yuxue; Lai, Tze Leung (2017) A new approach to regression analysis of censored competing-risks data. Lifetime Data Anal 23:605-625
Clarke, Christina A; Glaser, Sally L; Leung, Rita et al. (2017) Prevalence and characteristics of cancer patients receiving care from single vs. multiple institutions. Cancer Epidemiol 46:27-33
Han, Summer S; Ten Haaf, Kevin; Hazelton, William D et al. (2017) The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. Int J Cancer 140:2436-2443
Wender, Paul A; Hardman, Clayton T; Ho, Stephen et al. (2017) Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV. Science 358:218-223

Showing the most recent 10 out of 227 publications